Clinical Trials Sponsored by The Johrei Institute

Total 5134 results

The Cooper Institute
HealtheTech

Completed

HealtheTech Lifestyle Program

Obesity

United States
The Netherlands Cancer Institute

Completed

Trastuzumab in a Neo-adjuvant Regimen for HER2+ Breast Cancer - the TRAIN Study (TRAIN)

Breast Cancer | HER2 Positive

Netherlands
The Netherlands Cancer Institute

Not yet recruiting

Intradermal Ipilimumab and Nivolumab in High Risk Stage II Melanoma (MARIANE)

Melanoma

Netherlands
The Netherlands Cancer Institute

Recruiting

Image-guided Navigation During Robotic Sentinel Node Removal (N21LND)

Prostate Cancer

Netherlands
The Netherlands Cancer Institute

Recruiting

Body Surface Area-based vs Concentration-based Dosing of Cisplatin for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Women With Advanced Ovarian Cancer (CisCon)

Fallopian Tube Carcinoma | Peritoneal Cancer | FIGO Stage III Ovarian Cancer

Netherlands
The Netherlands Cancer Institute

Recruiting

Improved Implant for Reconstruction Purposes After Mandibular Resection (RifRam)

Head and Neck Cancer | Oral Cancer

Netherlands
The Netherlands Cancer Institute

Recruiting

The Prospective Observational COMPRAYA Cohort Study (COMPRAYA)

Cancer | Fertility Issues | Genetic Disease | Lifestyle | Survivorship | Distress, Emotional | Second Cancer

Netherlands
The Netherlands Cancer Institute

Not yet recruiting

Avoiding Sentinel Lymph Node Biopsy in Breast Cancer Patients After Neoadjuvant Chemotherapy (ASICS)

Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Sentinel Lymph Node
The Netherlands Cancer Institute

Terminated

Oral Docetaxel (ModraDoc/r) in Combination With Hormonal Treatment and Radiation Therapy in High-risk Prostate Cancer (DOP)

Prostatic Neoplasms

Netherlands
The Netherlands Cancer Institute

Active, not recruiting

Multicentric Randomised Trial for Resectable Gastric Cancer (CRITICS-II)

Gastric Cancer

Netherlands
The Netherlands Cancer Institute

Active, not recruiting

Substantially Improving the Cure Rate of High-risk BRCA1-like Breast Cancer (Subito)

Breast Cancer

Netherlands, France
The Hearthstone Institute, LLC

Completed

LEAD IT! An App to Enable Persons With Early Stage Dementia to Lead Group Activities for Their Peers

Alzheimer Disease | Dementia, Vascular | Dementia, Mixed

United States
The Netherlands Cancer Institute

Completed

Tracked Ultrasound for Patient Registration in Surgical Navigation During Abdominal Cancer Surgery

Abdominal Cancer

Netherlands
The Netherlands Cancer Institute

Unknown

Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcomas (DOREMY)

Myxoid Liposarcoma of Soft Tissue

Netherlands, United Kingdom, Norway, United States, Denmark
The Netherlands Cancer Institute

Completed

Olaparib and Radiotherapy in Inoperable Breast Cancer

Locally Advanced Malignant Neoplasm | Triple-Negative Invasive Breast Carcinoma | Inflammatory Breast Carcinoma

Netherlands
The Netherlands Cancer Institute

Active, not recruiting

Cisplatinum and Everolimus in Patients With Metastatic or Unresectable NEC of Extrapulmonary Origin

Neuroendocrine Carcinomas

Netherlands
The Netherlands Cancer Institute

Terminated

Monitoring MRI Changes Before and During Radiotherapy Treatment of Brain Tumors

Brain Tumor

Netherlands
The Netherlands Cancer Institute

Completed

Circulating Tumor Cells and Cytology in Cerebrospinal Fluid of Patients Clinically Suspected for Leptomeningeal Metastases

Meningeal Carcinomatosis

Netherlands
The Netherlands Cancer Institute

Terminated

Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility (NEOCON-F)

Cervical Cancer

Netherlands
The Netherlands Cancer Institute

Completed

Adaptive Dose-Escalated Multi-modality Image-guided RadiothErapy (ADMIRE)

Head and Neck Cancer

Netherlands
The Netherlands Cancer Institute

Completed

Safety, Feasibility and Cost-effectiveness of Genotype-directed Individualized Dosing of Fluoropyrimidines

Neoplasms

Netherlands
The Netherlands Cancer Institute

Completed

PET Response During Chemoradiation of Lung Cancer

NSCLC

Netherlands
The Netherlands Cancer Institute

Unknown

The Effectiveness of Patient Navigation in Cancer Care

Cancer

Netherlands
The Netherlands Cancer Institute

Terminated

Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer

Breast Cancer

Netherlands
The Netherlands Cancer Institute

Completed

Pharmacogenomic and Pharmacokinetic Safety and Cost-saving Analysis in Patients Treated With Fluoropyrimidines

Neoplasms

Netherlands
Sepsicure
The Rogosin Institute

Completed

Lipid Infusion in Dialysis Patients With Endotoxemia (LIPIDOSE)

Fatigue | End Stage Renal Disease (ESRD)

United States
The Netherlands Cancer Institute

Recruiting

Preoperative Accelerated Partial Breast Irradiation in Patients With Locally Recurrent or Second Primary Breast Cancer (PAPBI-3)

Breast Cancer

Netherlands
The Netherlands Cancer Institute

Recruiting

Peri-operative Slow-paced Breathing to Reduce Anxiety in Breast Cancer Surgery Patients (SlowPACE)

Anxiety

Netherlands
The Netherlands Cancer Institute

Not yet recruiting

LB-100 (PP2A Inhibitor) and Azenosertib (WEE1 Inhibitor) in Metastatic Colorectal Cancer Patients

Metastatic Colorectal Cancer
The Netherlands Cancer Institute

Not yet recruiting

LB-100 (PP2A Inhibitor) and Atezolizumab (PD-L1 Inhibitor) in Metastatic Colorectal Cancer Patients (CoLBAt)

Metastatic Microsatellite-stable Colorectal Cancer
The Netherlands Cancer Institute

Not yet recruiting

Subtherapeutic Dose of Piracetam as a Therapy Adherence Marker

Drug Adherence Marker
The Netherlands Cancer Institute

Recruiting

Vessel-based Ultrasound Registration

Abdominal Cancer

Netherlands
The Netherlands Cancer Institute

Recruiting

Ultrasound-guided Erector Spinae Plane Block Versus Paravertebral Block in Breast Cancer Patients Undergoing Mastectomy With Immediate Reconstruction - a Non-inferiority Trial (ESP)

Breast Cancer Patients Undergoing Mastectomy With Immediate Reconstruction

Netherlands
The Netherlands Cancer Institute

Recruiting

Tracer-Guided Surgery for Recurrent Prostate Cancer (Trace-II)

Prostate Cancer

Netherlands
The Netherlands Cancer Institute

Recruiting

Multispectral Fluorescence as a Tool to Separate Healthy and Disease Related Lymphatic Anatomies in Prostate Cancer. (SPLIT)

Prostate Cancer

Netherlands
The Netherlands Cancer Institute

Recruiting

Neo-adjuvant Nivolumab or Nivolumab With Ipilimumab in Advanced Cutaneous Squamous Cell Carcinoma Prior to Surgery (MATISSE)

Cutaneous Squamous Cell Carcinoma

Netherlands
The Netherlands Cancer Institute

Recruiting

Treatment of Locally Advanced VULvar CArcinoma in a Neoadjuvant Setting With Carboplatin and Paclitaxel Chemotherapy (VULCANize) (VULCANize)

Locally Advanced, Squamous Cell Carcinoma of the Vulva

Netherlands
The Netherlands Cancer Institute

Recruiting

Treatment of Metastatic Vulvar Carcinoma With Carboplatin and Paclitaxel Chemotherapy (CRAVAT)

Metastatic Squamous Cell Carcinoma of the Vulva

Netherlands
The Netherlands Cancer Institute

Recruiting

Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) (OVHIPEC-2)

Ovarian Cancer

Netherlands, United States, France, Denmark, Italy, Sweden, Ireland
The Netherlands Cancer Institute

Not yet recruiting

Sentinel Lymph Node Procedure in Testicular Germ Cell Tumour (SENATOR)

Testicular Germ Cell Tumor
The Netherlands Cancer Institute

Completed

ctDNA as a Biomarker for Treatment Response in HNSCC (PECAN)

Carcinoma, Squamous Cell of Head and Neck

Netherlands
The Netherlands Cancer Institute

Completed

ImmunoModulation by the Combination of Ipilimumab and Nivolumab Neoadjuvant to Surgery In Advanced or Recurrent Head and Neck Carcinoma (IMCISION)

Head and Neck Neoplasms | Immunotherapy

Netherlands
The Netherlands Cancer Institute

Completed

CYP3A4 Activity in Patients With Prostate Cancer Versus Male Patients With Other Solid Tumours

Prostate Cancer | Solid Tumor, Adult

Netherlands
The Netherlands Cancer Institute

Completed

Diagnostic Yield of Colonoscopy Surveillance in Testicular Cancer Survivors Treated With Platinum-based Chemotherapy (CATCHER)

Colorectal Neoplasms | Testicular Cancer

Netherlands
The Netherlands Cancer Institute

Completed

INtra-operative Evaluation of a Novel FLUorescENt C-mEt Tracer in Penile and Tongue (INFLUENCE)

Head and Neck Cancer | Penile Cancer

Netherlands
The Netherlands Cancer Institute

Active, not recruiting

High Dose Chemotherapy in Oligo-metastatic Homologous Recombination Deficient Breast Cancer (Oligo)

Breast Cancer

Netherlands
The Netherlands Cancer Institute

Completed

Optimal Sequencing of Treatment Options for Poor Risk mCRPC Previously Treated With Docetaxel (OSTRICh)

Metastasis | Prostate Cancer Metastatic

Netherlands
The Netherlands Cancer Institute

Unknown

Docetaxel, Oxaliplatin, Capecitabine, Bevacizumab and Trastuzumab in Patients With Locally Advanced or Metastatic Gastric Cancer (B-DOCT)

Metastatic Gastric Cancer | Adenocarcinoma of the Gastro-oesophageal Junction

Netherlands
The Netherlands Cancer Institute

Unknown

Technetium Based Radioguided Surgery for Prostate Cancer (TRACE) Study (TRACE)

Prostate Cancer

Netherlands
The Netherlands Cancer Institute

Terminated

Comparing Two Palliative Schemes of Radiotherapy for Head and Neck Cancer (COOPERATION)

Head and Neck Neoplasms

Netherlands

Clinical Trials Sponsored by The Johrei Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations